Immediate Impact

63 hit
Sub-graph 1 of 20

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Hit
100 years of the Warburg effect: A cancer metabolism endeavor
2024 Hit
8 intermediate papers

Works of Håkan Örlefors being referenced

Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors
2007
Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.
1998

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Håkan Örlefors 943 793 760 157 145 19 1.2k
Andreas Haldemann 736 0.8× 567 0.7× 543 0.7× 181 1.2× 105 0.7× 21 1.0k
Viktor Johanson 620 0.7× 542 0.7× 446 0.6× 143 0.9× 164 1.1× 43 1.0k
Klaas Pieter Koopmans 644 0.7× 452 0.6× 474 0.6× 329 2.1× 268 1.8× 30 1.1k
Gaston J H Franssen 704 0.7× 624 0.8× 538 0.7× 389 2.5× 385 2.7× 38 1.3k
Stephan U. Goebel 1.1k 1.2× 939 1.2× 740 1.0× 72 0.5× 198 1.4× 31 1.4k
Jean Claude Reubi 668 0.7× 464 0.6× 344 0.5× 173 1.1× 84 0.6× 9 978
Jörg Schmitt 1.0k 1.1× 807 1.0× 542 0.7× 132 0.8× 84 0.6× 10 1.4k
Michael Böhmig 838 0.9× 989 1.2× 590 0.8× 33 0.2× 172 1.2× 23 1.4k
Eric H. Liu 728 0.8× 728 0.9× 467 0.6× 89 0.6× 163 1.1× 30 1.1k
M. Manzoni 385 0.4× 506 0.6× 208 0.3× 224 1.4× 150 1.0× 38 938

All Works

Loading papers...

Rankless by CCL
2026